Monaco Asset Management SAM Takes $338,000 Position in American Well Corporation $AMWL

Monaco Asset Management SAM bought a new position in American Well Corporation (NYSE:AMWL) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 68,940 shares of the company’s stock, valued at approximately $338,000. Monaco Asset Management SAM owned 0.42% of American Well at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Headlands Technologies LLC bought a new position in American Well in the 2nd quarter worth $39,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in American Well in the 3rd quarter worth $62,000. Engineers Gate Manager LP bought a new position in American Well in the 2nd quarter worth $101,000. Prelude Capital Management LLC bought a new position in American Well in the 3rd quarter worth $86,000. Finally, JPMorgan Chase & Co. raised its holdings in American Well by 16.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company’s stock worth $131,000 after acquiring an additional 2,081 shares during the period. Institutional investors own 56.05% of the company’s stock.

American Well Price Performance

NYSE AMWL opened at $9.74 on Monday. The firm has a market capitalization of $161.11 million, a price-to-earnings ratio of -1.80 and a beta of 1.69. The company’s fifty day moving average is $6.62 and its two-hundred day moving average is $5.41. American Well Corporation has a 52-week low of $3.71 and a 52-week high of $9.83.

American Well (NYSE:AMWL) last posted its quarterly earnings results on Tuesday, May 5th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.77) by $0.11. The company had revenue of $54.88 million for the quarter, compared to analyst estimates of $51.54 million. American Well had a negative net margin of 37.02% and a negative return on equity of 32.11%. As a group, sell-side analysts expect that American Well Corporation will post -2.68 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently commented on the stock. TD Cowen lifted their target price on shares of American Well from $5.00 to $8.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Wall Street Zen upgraded shares of American Well from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. Stifel Nicolaus dropped their target price on shares of American Well from $6.00 to $5.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Finally, Morgan Stanley lifted their target price on shares of American Well from $6.00 to $6.50 and gave the stock an “equal weight” rating in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $7.13.

Insider Transactions at American Well

In other American Well news, insider Dmitry Zamansky sold 5,575 shares of the firm’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $5.30, for a total value of $29,547.50. Following the sale, the insider directly owned 241,080 shares in the company, valued at $1,277,724. This trade represents a 2.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last quarter, insiders have sold 9,664 shares of company stock valued at $51,219. Company insiders own 12.84% of the company’s stock.

American Well Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.